Drug Delivery - Snapshots and Highlights

Published by: Frost & Sullivan

Published: Apr. 24, 2007 - 46 Pages

Table of Contents

1. Executive Summary

1. Executive Summary

1. Introduction

2. Drug Delivery Topics

1. Overview and Scope

2. Snapshots and Highlights

1. Technology

1. Implant Technologies: Expected to Remain a Niche but Effective Method of Drug Delivery

2. Oral Extended Release: Snapshots and Benefits

3. Oral Controlled Release: Necessity or Compulsion?

4. Nanobiotechnology: Delivering Revenue and Exciting Promise for the Future

2. Business and Strategy

1. Drug Delivery's Increasing Importance to Big Pharma and Specialty Pharma

2. Drug Delivery is Integral to Lifecycle Strategies

3. Appendix

1. Decision Support Databases

1. Number of Biotechnology Companies

2. Pharmaceutical R&D Expenditure

3. Pharmaceutical R&D Expenditure As Percentage of Pharmaceutical Market

4. Total Healthcare Expenditure

5. Total Population

List of Figures

Chapter 2

Pharmaceuticals Market: Selected ER Product Analysis (U.S.), 2006

Top Specialty Pharmaceutical Companies: Business Model Adoption (U.S.), 2005-2006

Abstract

This Frost & Sullivan research service titled Drug Delivery: Snapshots and Highlights provides an insight into the pharmaceutical and biotech sectors and their strategies for new and innovative methods of drug delivery. In this research service, Frost & Sullivan's expert analysts examine the areas of implant delivery, oral modified release, and nanobiotechnology. Also discussed are business strategy trends currently important in drug delivery relative to business development, licensing, and lifecycle management.

Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:

• Drug delivery
• Pharmaceutical
• Biotechnology

Technologies
The following technologies are covered in this research:

• Implant delivery
• Oral modified release
• Nanobiotechnology
• Life cycle management
• Specialty pharmaceuticals

Market Overview
Patent Expiries and Generic Competition Increase Focus on Product Lifecycle Management

Drug delivery is an important facet of pharmaceutical product development. Changing a drug’s delivery method can help improve the product’s therapeutic benefits and revenue potential. The prolonged research and clinical evaluation process for drugs reduces the patent life for pharmaceuticals. This pressure compels pharmaceuticals developers to use novel product lifecycle management strategies to maximize revenue and extend IP. Altering a drug’s delivery technology has proven to be an effective strategy.

Continued technology evolution is also vital for drug development and future pharmacotherapy. "Business strategies have increasingly begun to include aspects of drug delivery technologies," notes the analyst of this research service. "Drug delivery companies can potentially enable pharmaceutical companies to revive late stage products by using new drug delivery platforms."

Drug Delivery Sector Continue to Focus on Innovative Methods

"Recent technological advances in drug delivery methods are opening up new avenues for manufacturers," says the analyst. "Marketing a drug with multiple available routes of administration in particular can increase product success." Within the realm of oral delivery, modified release (extended release/controlled release) is expected to bring benefits to companies from both product performance and business standpoints. Another promising technology, nanobiotechnology, is an exciting application for all forms of drug delivery and could have a substantial impact in the way drugs are being manufactured. Implantable drug delivery also has the potential to meet the distinctive therapeutic needs of some patients. Meanwhile, with the predominant indications of pain medications and hormone treatment, transdermal drug delivery has entered a new era with the active and traditional passive patch deliveries.

Overall, pharmaceutical companies now have an increasing amount of choices while determining the most successful route of delivery for their products. With increasing competition and R&D costs, partnerships between pharmaceutical and drug delivery companies are expected to continue to strengthen in the future, as companies seek to deal with issues such as lifecycle management and new product innovation.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.